Sidney Kimmel Foundation Announces Fifteen New Cancer Research Grant Recipients: To Date Over 200 Researchers Have Received More Than $40 Million

Share Article

Since 1997 The Sidney Kimmel Foundation for Cancer Research has selected research scientists and medical doctors from across the United States to receive two year grants under the Foundation's Kimmel Scholar program. This year's selection brings the total to 202 talented cancer researchers with each receiving a $200,000 award to further a specific cancer research project.

The Sidney Kimmel Foundation for Cancer Research has awarded more than $40 million in grants since 1997 to young cancer researchers.

The Sidney Kimmel Foundation for Cancer Research has awarded more than $40 million in grants since 1997 to young cancer researchers.

Many of the exceptional young scientists who have their careers 'jump started' by the Sidney Kimmel Foundation go on to receive millions of dollars in funding and make significant contributions to the field of cancer research.

Every year since 1997 The Sidney Kimmel Foundation for Cancer Research has selected research scientists and medical doctors from across the United States to receive two year grants under the Foundation's on-going Kimmel Scholar program. This year's selection brings the total to 202 talented cancer researchers who have been provided with grant money since the Foundation's inception, each receiving a $200,000 award to further a specific cancer research project.

The Kimmel Scholar Awards were created to advance the careers of gifted, young scientists involved in cancer research. Those selected are chosen for demonstrating the greatest promise and innovation in their work, must be in the early stages of their research career, and have not progressed far enough to have received major grants from the National Cancer Institute or other funding sources.

Sidney Kimmel, the organization's founder and chairman of the board of the Jones Group Inc. and president of Sidney Kimmel Entertainment, meets each year with the Foundation's medical advisory board as the esteemed group of leading cancer doctors narrows down the applicants from a pool of approximately 150. Since 1997 Sidney Kimmel has contributed more than $550 million to cancer centers and cancer research and another $100 million to the arts and Jewish continuity. Kimmel is a member of Warren Buffett's Giving Pledge having already committed more than half of his net worth to charitable causes.

Many of the exceptional young scientists who have their careers 'jump started' by the Sidney Kimmel Foundation for Cancer Research go on to receive millions of dollars in funding from the NCI and NIH and make significant contributions to the field of cancer research. Many report that they might never have achieved such success without first receiving the Kimmel grant.

The recipients for 2011 are:     

*Clark Chen M.D., Ph.D
Co-optation of G-protein coupled neurotransmitter receptor pathways in glioblastomas
Dana Farber Cancer Institute

Michela Garofalo Ph.D
Role of Tyrosine Kinase Receptors-deregulated microRNAs in tumorigenesis and gefitinib resistance of NSCLC
Ohio State University

Suzanne Gaudet Ph.D.
TNF signaling dynamics and cancer cell fate determination
Dana-Farber Cancer Institute

Geraldine Guasch Ph.D
Defining the cellular origin and the signaling pathways involved in epithelial cancers of transitional epithelia
Cincinnati Children's Hospital Medical Center

Min Guo Ph.D
Lysyl-tRNA Synthetase: A Novel Regulator of MITF in Melanoma
The Scripps Research Institute

Dimitrios lliopoulos Ph.D
Identification of Novel Signaling Networks in Pancreatic Cancer Stem Cells
Dana-Farber Cancer Institute

Mei Kong Ph.D.
Targeting PP2A and the Glutamine-Sensing Pathway as Cancer Treatment
Beckman Research Institute, City of Hope National Medical Center

*Roger Lo M.D., Ph.D
Exome sequencing of melanomas with acquired resistance to BRAF inhibitors
The Regents of the University of California, Los Angeles

Christine Mayr M.D., Ph.D
Cause and consequences of mRNAs with heterogeneous 3' ends for the pathogenesis of cancer
Memorial Sloan-Kettering Cancer Center

*Stephen Oh M.D, Ph.D.
Functional Characterization of LNK Mutations in Myeloproliferative Neoplasms
Washington University School of Medicine

*Dinesh Rao M.D., Ph.D
Unraveling the role of microRNA in hematolymphoid malignancy
The Regents of the University of California, Los Angeles (UCLA)

*Narendra Wajapeyee Ph.D
Deciphering and Targeting RAS-mutant Cancers
Yale University

Catherine Yan Ph.D.
Elucidating the Key End-Ligation Enyzme and Co-Factors Promoting Alternative DNA End-Joining
Beth Israel Deaconess Medical Center

*Eddy Yang M.D., Ph.D
Can inhibition of epidermal growth factor receptor (EGFR) signaling induce synthetic lethality with poly (ADP-Ribose) polymerase inhibition (PARPi) by generating a DNA repair defect?
University of Alabama-Birmingham

Hongwu Zheng Ph.D
Genetic and functional analysis of malignant glioma cell self-renewal and differentiation
Cold Spring Harbor Laboratory

  • Translational Scholars

The Foundation is particularly interested in helping physicians who are engaged in research which can rapidly be translated into benefits for patients with cancer. This year six of the fifteen awards have been designated for such "Translational Research."

The Sidney Kimmel Foundation for Cancer Research has also funded four cancer centers at San Diego, Memorial Sloan-Kettering Cancer Center, Thomas Jefferson University and Johns Hopkins University. The gift to Johns Hopkins, $150 million, is the largest gift ever received by that institution. In the area of arts and culture, The Kimmel Foundation has supported the Kimmel Center for the Performing Arts and National Museum of American Jewish History in Philadelphia as well as the United States Holocaust Memorial Museum in Washington D.C., among others. For more information visit http://www.kimmel.org.

# # #

Share article on social media or email:

View article via:

Pdf Print